Cargando…
The VACS Index Accurately Predicts Mortality and Treatment Response among Multi-Drug Resistant HIV Infected Patients Participating in the Options in Management with Antiretrovirals (OPTIMA) Study
OBJECTIVES: The VACS Index is highly predictive of all-cause mortality among HIV infected individuals within the first few years of combination antiretroviral therapy (cART). However, its accuracy among highly treatment experienced individuals and its responsiveness to treatment interventions have y...
Autores principales: | Brown, Sheldon T., Tate, Janet P., Kyriakides, Tassos C., Kirkwood, Katherine A., Holodniy, Mark, Goulet, Joseph L., Angus, Brian J., Cameron, D. William, Justice, Amy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965438/ https://www.ncbi.nlm.nih.gov/pubmed/24667813 http://dx.doi.org/10.1371/journal.pone.0092606 |
Ejemplares similares
-
Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial
por: Holodniy, Mark, et al.
Publicado: (2011) -
2432: A close examination of anti-retroviral drug selection and management in the optima study
por: Huang, Yuan, et al.
Publicado: (2018) -
White Blood Count, Albumin, and BMI Enhance VACS Index Prognostic Model, but Nadir CD4 and CD8 Metrics Do Not
por: Tate, Janet P, et al.
Publicado: (2017) -
Analysis of the Impact of Antiretroviral Drug Changes on Survival of Patients with Advanced-Stage AIDS with Multidrug-Resistant HIV Infection
por: Ma, Rui, et al.
Publicado: (2019) -
Decisiones optimas financieras
por: Robicheck, Alexander
Publicado: (1972)